SCHEMBL1244700

SCHEMBL1244700

O=C(O)c1cc2occ(C=Cc3ccccc3)c2[nH]1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 4/20 0.53
MAOB P27338 6/20 0.47
MAOA P21397 5/20 0.41
HPGD P15428 2/20 0.39
HSD17B10 Q99714 2/20 0.39
MEN1 O00255 1/20 0.39
USP2 O75604 1/20 0.39
ALDH1A1 P00352 1/20 0.39
KMT2A Q03164 1/20 0.39
PTPN1 P18031 2/20 0.38
HNF4A P41235 1/20 0.37
KDM4E B2RXH2 1/20 0.36
MAPT P10636 1/20 0.36
SRD5A2 P31213 1/20 0.36
DPYD Q12882 1/20 0.36
GRIK1 P39086 1/20 0.36
GRIA1 P42261 1/20 0.36
GRIA2 P42262 1/20 0.36
GRIA3 P42263 1/20 0.36
GRIA4 P48058 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1244698 1.00 DAO (0.53) DAOMAOBMAOAHPGDHSD17B10
SCHEMBL12890086 0.83 ADORA3 (0.43) DAOMAOBMAOAHPGDMEN1
SCHEMBL1242703 0.81 DAO (0.56) DAOHPGDHSD17B10MEN1USP2
SCHEMBL1242700 0.81 DAO (0.56) DAOHPGDHSD17B10MEN1USP2
SCHEMBL1244885 0.79 DAO (0.61) DAOMAOBMAOAHPGDHSD17B10
SCHEMBL1244142 0.78 DAO (0.59) DAOHPGDHSD17B10MEN1USP2
SCHEMBL27779792 0.75 DAO (0.49) DAOHPGDHSD17B10MEN1USP2
SCHEMBL1244669 0.69 DAO (1.00) DAOHPGDHSD17B10MEN1USP2
SCHEMBL1244762 0.69 DAO (1.00) DAOHPGDHSD17B10MEN1USP2
SCHEMBL1244217 0.69 DAO (0.65) DAOHPGDHSD17B10MEN1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7884124-B2 such as 2-Fluoro-4H-furo[3,2-b]pyrrole-5-carboxylate acid, used for the treatment of neuropathic pain, Alzheimer's disease, schizophrenia, ataxia and convulsions SEPRACOR INC. (US) 2011-02-08 US disclosed
US-20100029741-A1 FUSED HETEROCYCLES SEPRACOR INC. (US) 2010-02-04 US disclosed
US-20100022612-A1 FUSED HETEROCYCLES SEPRACOR INC. (US) 2010-01-28 US disclosed
US-7579370-B2 Fused heterocycles SEPRACOR INC. (US) 2009-08-25 US disclosed
US-20080058395-A1 Fused heterocyclic inhibitors of D-amino acid oxidase SEPRACOR INC. (US) 2008-03-06 US disclosed
US-20080004327-A1 FLUORO-SUBSTITUTED INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2008-01-03 US disclosed
US-20080004328-A1 FUSED HETEROCYCLES SEPRACOR INC. (US) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022612-A1 FUSED HETEROCYCLES AHR, HAX1, HRH3 DAO 2452/4885MAOB 2022/4885MAOA 1546/4885
US-20080058395-A1 Fused heterocyclic inhibitors of D-amino acid oxidase DAO, DDO, AOX1 DAO 1/4885MAOB 23/4885MAOA 21/4885
US-20100029741-A1 FUSED HETEROCYCLES CHRNA4, CHRNB4, CHRNA3 DAO 1545/4885MAOB 656/4885MAOA 587/4885
US-20080004328-A1 FUSED HETEROCYCLES HRH3, HRH4, AHR DAO 2936/4885MAOB 2088/4885MAOA 1746/4885
US-20080004327-A1 FLUORO-SUBSTITUTED INHIBITORS OF D-AMINO ACID OXIDASE DAO, DDO, AOX1 DAO 1/4885MAOB 14/4885MAOA 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.